Human telomerase RNA component (hTERC) gene amplification detected by FISH in precancerous lesions and carcinoma of the larynx

Diagnostic Pathology

Hong-gang Liu¹  Cheng Tian¹  Xiao-li Dong²  Yu Liu² 

[1] Department of Pathology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China;Department of Pathology, Capital Medical University, Beijing, 100069, China

关键词: Fluorescent in situ hybridization;    Amplification;    Human telomerase RNA component gene;    Laryngeal carcinoma;   

Others  :  808124
DOI  :  10.1186/1746-1596-7-34

 received in 2012-01-25, accepted in 2012-03-30,  发布年份 2012

【 摘 要 】

Background

Gain of 3q26 is frequently observed in squamous cell carcinomas of mucosal origin, including those originating in the head and neck region. The human telomerase RNA component (hTERC) gene, which is located on chromosome 3q26, encodes for an RNA subunit of telomerase that maintains the length of telomeres through cellular divisions, and is activated in malignant diseases. The present study was designed to detect hTERC amplification in laryngeal lesions and evaluate whether this might serve as a supportive biomarker in histopathological analysis for in the diagnosis of laryngeal lesions.

Methods

Fluorescent in situ hybridization (FISH) was applied on formalin-fixed paraffin-embedded blocks of 93 laryngeal specimens, including 14 normal epithelium (NE), 15 mild dysplasia (Md), 18 moderate dysplasia (MD), 16 severe dysplasia (SD), 9 carcinoma in situ (CIS), and 21 invasive carcinoma (IC)).

Results

By histopathologic examination, hTERC amplification rates in NE, Md, MD, SD, CIS and IC cases were 0% (0/14), 13.33% (2/15), 72.22% (13/18), 81.25% (13/16), 100% (9/9) and 100% (21/21), respectively. Amplification of hTERC was significantly associated with histopathologic diagnosis (P < 0.0001). The percentage of hTERC amplification in patients with MD, SD, CIS, and IC was significantly higher than those with NE or Md (P < 0.0001). The number of cells with abnormal signals increased and the abnormal signal patterns were diversified with increasing severity of laryngeal dysplasia (P < 0.0001).

Conclusions

The hTERC amplification is important in the development of laryngeal squamous cell carcinoma (LSCC). FISH detection of hTERC amplification may provide an effective approach in conjunction with histopathologic evaluation for differential diagnosis of laryngeal lesions.

Virtual Slides

The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/2226606266791985 webcite

【 授权许可】

   
2012 Liu et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

【 参考文献 】

• [1]Licitra L, Bernier J, Grandi C, Locati L, Merlano M, Gatta G, Lefebvre JL: Cancer of the larynx. Crit Rev Oncol Hematol 2003, 47:65-80.
• [2]Mao L, Hong WK, Papadimitrakopoulou VA: Focus on head and neck cancer. Cancer Cell 2004, 5:311-316.
• [3]Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ: Cancer statistics, 2005. CA Cancer J Clin 2005, 55:10-30.
• [4]Sugita M, Tanaka N, Davidson S, Sekiya S, Varella-Garcia M, West J, Drabkin HA, Gemmill RM: Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung. Cancer Genet Cytogenet 2000, 117:9-18.
• [5]Yokoi S, Yasui K, Iizasa T, Imoto I, Fujisawa T, Inazawa J: TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers. Clin Cancer Res 2003, 9:4705-4713.
• [6]Fan YB, Ye L, Wang TY, Wu GP: Correlation between morphology and human telomerase gene amplification in bronchial brushing cells for the diagnosis of lung cancer. Diagn Cytopathol 2010, 38:402-406.
• [7]Hermsen M, Guervos MA, Meijer G, Baak J, van Diest P, Marcos CA, Sampedro A: New chromosomal regions with high-level amplifications in squamous cell carcinomas of the larynx and pharynx, identified by comparative genomic hybridization. J Pathol 2001, 194:177-182.
• [8]Singh B, Stoffel A, Gogineni S, Poluri A, Pfister DG, Shaha AR, Pathak A, Bosl G, Cordon-Cardo C, Shah JP, Rao PH: Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas. Am J Pathol 2002, 161:365-371.
• [9]Ashman JN, Patmore HS, Condon LT, Cawkwell L, Stafford ND, Greenman J: Prognostic value of genomic alterations in head and neck squamous cell carcinoma detected by comparative genomic hybridisation. Br J Cancer 2003, 89:864-869.
• [10]Hopman AH, Theelen W, Hommelberg PP, Kamps MA, Herrington CS, Morrison LE, Speel EJ, Smedts F, Ramaekers FC: Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer. J Pathol 2006, 210:412-419.
• [11]Caraway NP, Khanna A, Dawlett M, Guo M, Guo N, Lin E, Katz RL: Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma. Gynecol Oncol 2008, 110:37-42.
• [12]Yen CC, Chen YJ, Pan CC, Lu KH, Chen PC, Hsia JY, Chen JT, Wu YC, Hsu WH, Wang LS, Huang MH, Huang BS, Hu CP, Chen PM, Lin CH: Copy number changes of target genes in chromosome 3q25.3-qter of esophageal squamous cell carcinoma: TP63 is amplified in early carcinogenesis but down-regulated as disease progressed. World J Gastroenterol 2005, 11:1267-1272.
• [13]Imoto I, Yuki Y, Sonoda I, Ito T, Shimada Y, Imamura M, Inazawa J: Identification of ZASC1 encoding a Kruppel-like zinc finger protein as a novel target for 3q26 amplification in esophageal squamous cell carcinomas. Cancer Res 2003, 63:5691-5696.
• [14]Meyerson M: Role of telomerase in normal and cancer cells. J Clin Oncol 2000, 18:2626-2634.
• [15]Guilleret I, Yan P, Guillou L, Braunschweig R, Coindre JM, Benhattar J: The human telomerase RNA gene (hTERC) is regulated during carcinogenesis but is not dependent on DNA methylation. Carcinogenesis 2002, 23:2025-2030.
• [16]Tu Z, Zhang A, Wu R, Jiang J, Li Y, Wulan N, Li J, Zhang Y, Li Y, Chen Z, Wei L: Genomic amplification of the human telomerase RNA gene for differential diagnosis of cervical disorders. Cancer Genet Cytogenet 2009, 191:10-16.
• [17]Jiang J, Wei LH, Li YL, Wu RF, Xie X, Feng YJ, Zhang G, Zhao C, Zhao Y, Chen Z: Detection of TERC amplification in cervical epithelial cells for the diagnosis of high-grade cervical lesions and invasive cancer: a multicenter study in China. J Mol Diagn 2010, 12:808-817.
• [18]Xiang L, Yang H, Li J, Wu X, Zhou X: Different amplification patterns of the human telomerase RNA gene in invasive cervical carcinomas and cervical intraepithelial neoplasia grade III. Diagn Cytopathol 2011. doi: 10.1002/dc.21635
• [19]Ha PK, Califano JA: The molecular biology of laryngeal cancer. Otolaryngol Clin North Am 2002, 35:993-1012.
• [20]Cohen SB, Graham ME, Lovrecz GO, Bache N, Robinson PJ, Reddel RR: Protein composition of catalytically active human telomerase from immortal cells. Science 2007, 315:1850-1853.
• [21]Cao Y, Bryan TM, Reddel RR: Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells. Cancer Sci 2008, 99:1092-1099.
• [22]Soder AI, Hoare SF, Muir S, Going JJ, Parkinson EK, Keith WN: Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene 1997, 14:1013-1021.
• [23]Sasiadek M, Stembalska-Kozlowska A, Smigiel R, Krecicki T, Blin N, Mirghomizadeh F: Microsatellite and chromosome instability in squamous cell laryngeal carcinoma. Int J Oncol 2001, 19:401-405.
• [24]Huang Q, Yu GP, McCormick SA, Mo J, Datta B, Mahimkar M, Lazarus P, Schaffer AA, Desper R, Schantz SP: Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer 2002, 34:224-233.
• [25]Hashimoto Y, Oga A, Kawauchi S, Furuya T, Shimizu N, Nakano T, Imate Y, Yamashita H, Sasaki K: Amplification of 3q26 approximately qter correlates with tumor progression in head and neck squamous cell carcinomas. Cancer Genet Cytogenet 2001, 129:52-56.
• [26]Patmore HS, Ashman JN, Stafford ND, Berrieman HK, MacDonald A, Greenman J, Cawkwell L: Genetic analysis of head and neck squamous cell carcinoma using comparative genomic hybridisation identifies specific aberrations associated with laryngeal origin. Cancer Lett 2007, 258:55-62.
• [27]Taubald A, Liehr T, Ries J, Girod S, Hassfurter E, Gebhart E: CGH-detected DNA sequence copy number amplifications can be confirmed by interphase-FISH: new possiblities for prognostic approaches in oral squamous cell carcinomas. Int J Mol Med 1998, 2:555-560.
• [28]Bockmuhl U, Schluns K, Kuchler I, Petersen S, Petersen I: Genetic imbalances with impact on survival in head and neck cancer patients. Am J Pathol 2000, 157:369-375.
• [29]Luzar B, Poljak M, Marin IJ, Gale N: Telomerase reactivation is an early event in laryngeal carcinogenesis. Mod Pathol 2003, 16:841-848.
• [30]Luzar B, Poljak M, Gale N: Telomerase catalytic subunit in laryngeal carcinogenesis-an immunohistochemical study. Mod Pathol 2005, 18:406-411.